We are convinced that the pooling of the expertise of the project partners will make it possible to refine the prediction and diagnosis of transplant rejections, for a more effective follow-up and immune diagnosis of patients.
KTD-innov is a public-private consortium of research teams, clinical centres and industrial partners. The project brings together researchers, nephrologists, statisticians and public health specialists around the same objective. Together, they adopt a multidimensional and transversal diagnostic approach as a world first.
The KTD-innov project is funded to the tune of nearly €9 million over 5 years (2018-2022) by the French National Research Agency as part of the Future Investment Programme.